Infectious Diseases Pharmacy

The first examination in Infectious Diseases Pharmacy will be administered in Fall 2018.
The application will open on or about May 1, 2018.

The BPS Board Certified Infectious Diseases Pharmacist (BCIDP) program is a credential for pharmacists who have met the eligibility criteria below and specialize in the use of microbiology and pharmacology to develop, implement, and monitor drug regimens that incorporate the pharmacodynamics and pharmacokinetics of antimicrobials to optimize therapy for patients.

The purpose of the BCIDP program is to validate that the pharmacist has the advanced knowledge and experience to optimize patient outcomes by:

  • Using clinical and evidence-driven knowledge to develop appropriate antimicrobial therapies to more rapidly resolve infections while decreasing adverse events, complications, and resistance.
  • Providing direct patient care through interprofessional health care teams, collaborative leadership of antimicrobial stewardship programs, education of health care providers, preventive services including immunizations
  • Advocating for appropriate antimicrobial utilization.
  • Improving public health by optimizing antimicrobial potential in individual patients and narrowing the resistance trends that occur in society by preventing progression of antimicrobial resistance and infectious diseases.

 

Eligibility Requirements (all practice eligibility requirements must be met prior to the candidate sitting for the examination)

The minimum requirements for Infectious Diseases Pharmacy specialty certification are:

  • Graduation from a pharmacy program accredited by the Accreditation Council for Pharmacy Education (ACPE) or a program outside the U.S. that qualifies the individual to practice in the jurisdiction.
  • Current, active license to practice pharmacy in the U.S. or another jurisdiction.
  • Completion of four (4) years of practice experience (post-pharmacist licensure) with at least 50% of time spent in infectious diseases pharmacy activities as defined by the Infectious Diseases Pharmacy Content Outline.

**Practice experience should be from within the past seven years prior to the application date.

OR

  • Completion of a PGY1 residency * plus two (2) additional years of practice (post-pharmacist licensure) with at least 50% of time spent in Infectious Diseases pharmacy activities as defined by the Infectious Diseases Pharmacy Content Outline.

**Practice experience should be from within the past seven years prior to the application date.

OR

  • Completion of a specialty (PGY2) residency* in Infectious Diseases pharmacy.
  • Achieving a passing score on the Infectious Diseases Pharmacy Specialty Certification Examination.

Examination Content – Infectious Diseases Pharmacy Content Outline

(Refer to the Infectious Diseases Pharmacy Content Outline for details.)

  • Domain 1: Patient Management and Therapeutics (50% of the examination)
  • Domain 2: Education, Research and Scholarship (20% of the examination)
  • Domain 3: Antimicrobial Stewardship and Practice Management (25% of the examination)
  • Domain 4: Public Health and Patient Advocacy (5% of the examination)

Recertification

(The Professional Development Programs for the recertification of BCIDP have not been approved.)

Pharmacists who earn the designation Board Certified Infectious Diseases Pharmacist® (BCIDP) will be required to maintain their certification over a seven year period by completing one of the following professional development activities:

  • Achieving a passing score on the 100-item, multiple-choice objective recertification examination (administered by BPS), based on the content outline for the Infectious Diseases Pharmacy Specialty in their seventh year following initial certification; Or
  • Earning 100 hours of continuing education credit provided by a BPS-approved professional development program provider.  Infectious Diseases Pharmacy Preparatory Review and Recertification Courses offered by any of the approved providers may only be completed for recertification credit up to two times, in nonconsecutive years, during the 7-year recertification cycle.

**To achieve the 100 hour requirement, the BCIDP may participate in recertification offerings from any of the BPS-approved professional development providers

Board Certified Infectious Pharmacists® are also required to pay the BPS Annual Certification Maintenance fee of $125 each year for years one through six and a $400 recertification fee in year seven.

Individuals with more than one BPS certification will only be assessed one BPS Annual Certification Maintenance Fee each year.